Quimioterapia com Cisplatinum, Vinblastina e Bleomicina (PVB) em Pacientes Portadores de Tumores Germinativos Avançados do Testiculo

Authors

  • Wagner Brant Moreira Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Eduardo Carvalho Brandão Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Eduardo Nascimento Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Eugênio Baumgratz Lopes Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • João Augusto M. Teixeira Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Maria do Carmo L. R. Vieira Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Maria Nunes Alvares Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil
  • Sebastião Cabral Filho Serviço de Oncologia Clínica. Santa Cosa de Misericórdia. Centro de Quimioterapia Antiblástica e Imunoterapia, Hospital Belo Horizonte. Belo Horizonte (MG), Brasil

DOI:

https://doi.org/10.32635/2176-9745.RBC.1986v32n2.3238

Keywords:

Testicular Tumor, Chemotherapy

Abstract

Twenty eight available patients with advanced germ cell testis cancer were treated by combination chemotherapy (CT) with Cisplatinun, Vinblastine and Bleomycin (PVB) and followed by a median period of 35.5 months (range 5-76). Complete remission (CR) with CT alone was achieved in 12/28 (431%) patients, CR with CT associated to radical surgery in 4/28 (14%) patients, with a total of 16/28 (57%) patients becoming disease-free. CR was achieved in 6/7 (86%) patients with minimal advanced disease and alI of them are long term disease free survivors. CR was achieved in 10/21 (47,6%) patients with bulky advanced disease and five (24%) of them are still in their first remission. PVB was an effective and well tolerated treatment for patients with minimal advanced disease but were of less eficacy (only 24% Jong term disease free survivors) in those with bulky disease. Survival curve as described by Kaplan-Meier method, showed a media, survival of 36.6 months and a four-year disease free survival of 48010 patients. Discussion about new chemotherapeutic treatments are presented.

Downloads

Download data is not yet available.

References

Williams SD, Einhorn LH. Neoplasms of the testis. in: Calabresi P, Schein P, Rosenberg SA, eds Medical oncology: basic principies and clinical management of cancer. New York; Macmillan 1985; 1077-1088.

Einhorn LH, Williams SD. The management of disseminated testicular cancer. In: Einhorn LH, ed Testicular tumors management and treatment. New York; 1980: 117-149.

Einhorn LH, Donohue JP. Peckham MJ, Williams SD, Loehrer PJ. Cancer of the testis. in: De Vita VT, Heilman S, Rosenberg SA, eds Cancer: Principies and pratice of oncology. Philadelphia, JB Lippincott 1985: 979-1011.

Einhorn LH, Donohue JP. Cis-diamminedichioroplatinum, Vinblastine, and Bleomycin combination chemotherapy in disseminated testicular cancer. Ann inter Med 1977; 87: 293-298. DOI: https://doi.org/10.7326/0003-4819-87-3-293

S. Hainsworth JD, Greco FA. Testicular germ cell neoplasms. Amer J Med, 1983; 75: 817-832. DOI: https://doi.org/10.1016/0002-9343(83)90413-8

Stoter G, Vendrik CPJ, Struyvenberg A, et al. Five years survival of patients with disseminated nonseminornatous testicular cancer treated with cisplatinun, vinbIastine and bleomycin. Cancer 1984; 54: 1521-1524. DOI: https://doi.org/10.1002/1097-0142(19841015)54:8<1521::AID-CNCR2820540808>3.0.CO;2-8

Wettfiaufer JN, Feiner AS, Robison WA. Vincristine, cisplatin and bleomycin with surgery in the management of advanced metastatic monseminomatous testis tumors. Cancer. 1984; 53: 203-209. DOI: https://doi.org/10.1002/1097-0142(19840115)53:2<203::AID-CNCR2820530203>3.0.CO;2-U

Einhorn LH, Williams SD. Chemotherapy of disseminated testicular cancer: a random prospective study. Cancer 1980; 46: 1339-1344. DOI: https://doi.org/10.1002/1097-0142(19800915)46:6<1339::AID-CNCR2820460607>3.0.CO;2-J

Huben RP, Williams PD, Pontes JE, Panahon AM, Murphy GP. Seminoma at Roswell Park, 1970 to 1979; an analysis for treatment failures. Cancer 1984; 53:1451-1455. DOI: https://doi.org/10.1002/1097-0142(19840401)53:7<1451::AID-CNCR2820530704>3.0.CO;2-U

Ozois AF, Deisseroth AB, Javadpour N, Bariock A, Messerschimidt GL, Vong RC. Treatment of poor prognostic non-seminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regíment. Cancer 1983; 51: 1803-1807. DOI: https://doi.org/10.1002/1097-0142(19830515)51:10<1803::AID-CNCR2820511008>3.0.CO;2-F

Published

2023-08-07

How to Cite

1.
Moreira WB, Brandão EC, Nascimento E, Lopes EB, Teixeira JAM, Vieira M do CLR, Alvares MN, Cabral Filho S. Quimioterapia com Cisplatinum, Vinblastina e Bleomicina (PVB) em Pacientes Portadores de Tumores Germinativos Avançados do Testiculo. Rev. Bras. Cancerol. [Internet]. 2023 Aug. 7 [cited 2024 May 17];32(2):81-8. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3238

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)